You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 289 No. 15, April 16, 2003 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Letters
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on ISI (1)
 •Contact me when this article is cited
 Related Content
 •Related articles
 •Similar articles in JAMA
 Topic Collections
 •Neurology
 •Cerebrovascular Disease
 •Stroke
 •Alert me on articles by topic

Reducing the Risk of Stroke

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

To the Editor: In their Scientific Review article about stroke prevention, Dr Straus and colleagues1 stated that the benefits of antihypertensive therapy are related to the degree of blood pressure lowering, irrespective of which drugs are used. Although the authors cite the PROGRESS trial2 as supporting this position, we think that the results may suggest a different interpretation.

According to the PROGRESS authors, a 5-mm Hg decrease in systolic blood pressure (SBP) with perindopril alone should have reduced the risk of stroke recurrence by 14% in their population with a history of stroke. Instead, however, the authors found that this degree of blood pressure lowering translated into only a 5% reduction in the risk of stroke, yielding a net 9% blood pressure–independent stroke-producing effect. In contrast, a 12-mm Hg decrease in SBP with perindopril plus indapamide, which would have been predicted to produce a stroke risk reduction of 33%, . . . [Full Text of this Article]

Albert Fournier, MD
Department of Nephrology

Roxana Oprisiu, MD
Department of Geriatrics

Michel Andrejak, MD
Pharmacology Laboratory
Centre Hospitalier Universitaire d'Amiens
Amiens, France

Jean Michel Achard, MD, PhD
Department of Physiology
Centre Hospitalier Universitaire Limoges
Limoges, France

Leonardo Fernandez, MD, PhD
Department of Pathology
Yale Medical School
New Haven, Conn


RELATED ARTICLES

Reducing the Risk of Stroke
Kamakshi Lakshminarayan and David C. Anderson
JAMA. 2003;289(15):1928.
EXTRACT | FULL TEXT  

Reducing the Risk of Stroke
Howard S. Kirshner
JAMA. 2003;289(15):1928.
EXTRACT | FULL TEXT  

Reducing the Risk of Stroke
James M. Gebel and Louis R. Caplan
JAMA. 2003;289(15):1928.
EXTRACT | FULL TEXT  

Reducing the Risk of Stroke—Reply
Sharon E. Straus, Finlay A. McAlister, and Sumit R. Majumdar
JAMA. 2003;289(15):1929.
EXTRACT | FULL TEXT  

New Evidence for Stroke Prevention: Scientific Review
Sharon E. Straus, Sumit R. Majumdar, and Finlay A. McAlister
JAMA. 2002;288(11):1388-1395.
ABSTRACT | FULL TEXT  






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2003 American Medical Association. All Rights Reserved.